Net profit of Marksans Pharma rose 15.66% to Rs 90.55 crore in the quarter ended March 2025 as against Rs 78.29 crore during the previous quarter ended March 2024. Sales rose 26.51% to Rs 708.46 crore in the quarter ended March 2025 as against Rs 560.01 crore during the previous quarter ended March 2024.
For the full year,net profit rose 21.32% to Rs 380.58 crore in the year ended March 2025 as against Rs 313.70 crore during the previous year ended March 2024. Sales rose 20.46% to Rs 2622.85 crore in the year ended March 2025 as against Rs 2177.41 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 708.46 | 560.01 | 27 | 2622.85 | 2177.41 | 20 |
| OPM % | 17.75 | 19.58 | - | 20.15 | 21.06 | - |
| PBDT | 138.84 | 121.33 | 14 | 587.35 | 497.80 | 18 |
| PBT | 116.09 | 100.28 | 16 | 503.97 | 423.53 | 19 |
| NP | 90.55 | 78.29 | 16 | 380.58 | 313.70 | 21 |